Compare Johnson & Johnson (JNJ) vs Tencent Music Entertainment Group - ADR (TME) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Johnson & Johnson vs Tencent Music Entertainment Group - ADR — how do they compare? Johnson & Johnson trades at $249.38 (market cap $598.96B), while Tencent Music Entertainment Group - ADR trades at $8.94 (market cap $15.08B). The key difference: Johnson & Johnson is far larger — about 39.7× Tencent Music Entertainment Group - ADR's market cap, and Tencent Music Entertainment Group - ADR pays the higher dividend (2.62%). Which is the better fit depends on your goals.
| JNJ | TME | |
|---|---|---|
Market Cap | $598.96B | $15.08B |
Volume | 6,156,228 | — |
Sector | Health | Media |
52-Week High | $267.24 | $26.36 |
52-Week Low | $164.36 | $8.16 |
Enterprise Value | $631.90B | $11.85B |
Dividend Yield | 2.15% | 2.62% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Johnson & Johnson (JNJ) trades at $249.58, down 1.37% today, amid a generally bullish technical outlook with strong moving average signals. The company reported robust Q2 2026 earnings, beating EPS estimates and raising full-year guidance, with revenue growth to $94.19B in 2025 and a net income margin of 21.48%. Recent news highlights strong institutional interest and positive analyst sentiment, though the stock faces pressure from MedTech segment misses despite overall strength.
The outlook for JNJ remains positive, supported by solid fundamentals, a consistent dividend history, and upward revised earnings guidance. Key risks include competitive pressures in pharmaceuticals, regulatory hurdles, and execution challenges in the MedTech division. With a consensus price target of $279.33, representing ~12% upside, the stock offers a compelling opportunity for long-term investors, balanced by sector-specific volatility and macroeconomic factors.
TME trades at $9.19, up 0.77% today, with a bullish technical signal from moving averages. The company reported strong 2025 results with revenue of $32.9B and net income of $11.1B, though recent quarterly earnings have missed expectations. Analyst consensus is mixed with 45.8% buy ratings and a $14 price target, while cash flow trends show significant investment activity.
The outlook remains cautiously optimistic with solid profitability metrics and ecosystem expansion through initiatives like SEND audio technology. Key risks include competitive pressures and execution challenges in premium content delivery. The stock presents value opportunity given reasonable valuation multiples relative to earnings growth potential.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Johnson & Johnson
Johnson & Johnson manufactures health care products and provides related services for the consumer, pharmaceutical, and medical devices and diagnostics markets. The Company sells products such as skin and hair care products, acetaminophen products, pharmaceuticals, diagnostic equipment, and surgical equipment in countries located around the world.
Read more on JNJ →About Tencent Music Entertainment Group - ADR
TME is the largest online music service provider in China. It was founded in 2016 with the business combination of QQ Music (founded in 2005), Kuwo Music (founded in 2005) and Kugou Music (founded in 2004) streaming platforms. Tencent is the largest shareholder of TME with over 50% shares and over 90% voting rights held. TME also provides social entertainment services, including music live audio/video broadcasts and online concert services through the three platforms mentioned above, and online karaoke through an independent platform WeSing.
Read more on TME →
